Roger Vaillancourt
About Roger Vaillancourt
Roger Vaillancourt is the Director of eCOA Operations at Suvoda, where he has worked since 2022. He has over 20 years of experience in eClinical services, having held various roles at companies such as PHT Corporation, ERT, and BiogenIdec.
Current Role at Suvoda
Roger Vaillancourt serves as the Director of eCOA Operations at Suvoda, a position he has held since 2022. In this role, he oversees the operations related to electronic Clinical Outcome Assessments (eCOA), contributing to the company's mission in the clinical research sector. His leadership in this position is supported by over 20 years of experience in the eClinical field, particularly in eCOA services delivery management.
Previous Experience in eCOA Services
Prior to his current role, Roger Vaillancourt worked extensively in eCOA services delivery management at PHT Corporation, ERT, and Clario. His experience includes acting as a Release Train Engineer for the eCOA Core Product Delivery process, where he facilitated the implementation and management of eCOA solutions. This background has equipped him with a deep understanding of the complexities involved in clinical data collection and patient engagement.
Career History and Roles
Roger Vaillancourt has held various positions throughout his career, including Manager of Client Services at PHT Corporation and ERT, and Principal Project Manager at Phase Forward. His career spans over two decades, during which he has gained expertise in project management, client services, and technical consulting. His roles have included responsibilities in eClinical operations, data analytics services, and program management.
Educational Background and Skills
Roger Vaillancourt possesses a robust educational background that complements his extensive professional experience. He has developed a diverse skill set in project management, business analysis, and technical writing. His work has involved delivering data analytics services for pharmaceutical and health networks, showcasing his ability to bridge technical and operational aspects of clinical research.
Professional Impact and Contributions
Throughout his career, Roger Vaillancourt has made significant contributions to the field of eClinical operations. His involvement in EDC service delivery with Phase Forward and Oracle highlights his commitment to enhancing clinical trial processes. By leveraging his extensive experience, he has played a key role in improving the efficiency and effectiveness of eCOA solutions in the clinical research landscape.